Literature DB >> 4055547

Intraphagocytic penetration of macrolides: in-vivo comparison of erythromycin and spiramycin.

J J Pocidalo, F Albert, J F Desnottes, S Kernbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4055547     DOI： 10.1093/jac/16.suppl_a.167

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.

Authors:  Y Hirakata; M Kaku; K Tomono; K Tateda; N Furuya; T Matsumoto; R Araki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 3.  Pharmacodynamics and pharmacokinetics of spiramycin and their clinical significance.

Authors:  I Brook
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

4.  Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

Authors:  J Chastre; P Brun; J B Fourtillan; P Soler; G Basset; C Manuel; J L Trouillet; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 5.  Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  S M Holliday; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin.

Authors:  S Bailly; J J Pocidalo; M Fay; M A Gougerot-Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

7.  Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.

Authors:  E Vallée; E Azoulay-Dupuis; J J Pocidalo; E Bergogne-Bérézin
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

8.  Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus.

Authors:  E Schoondermark-Van de Ven; J Galama; W Camps; T Vree; F Russel; J Meuwissen; W Melchers
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa.

Authors:  Y Hirakata; M Kaku; R Mizukane; K Ishida; N Furuya; T Matsumoto; K Tateda; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.